What is BBIO's five-year median P/S?

26.2x. Half of BBIO's weekly readings since August 2022 were higher and half were lower. This page has 221 weekly readings, from Aug 1, 2022 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares BBIO only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Bridgebio Pharma Inc (BBIO) P/S ratio history

Health Care

$68.56

Latest weekly close · Market cap $13.4B

Below its usual range

As of Oct 24, 2026

BBIO's P/S of 18.8x is lower than 83% of its weekly readings since August 2022.

Weekly P/S since August 2022

P/S each weekMiddle half of its readingsMedian 26.2×

Median: 26.2×
Low to high: 12.3×–70.7×
Versus median: -28%
History starts: August 2022

P/S

17thpercentile

of its weekly readings since August 2022

Below its usual range

Growth, last 12 months vs the year before

Revenue: +202%accelerating
EPS: n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.

PriceRevenue, last 12 months100 = first reading

P/S at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

BBIO P/S at each year-end
Year-end	P/S	5-year percentile
Dec 29, 2025	42.4×	85
Dec 30, 2024	24.3×	72
Dec 25, 2023	n/a	Too little history
Dec 26, 2022	12.7×	Too little history

Health Care peers on P/S

Each percentile compares a stock with its own last five years.

Compare BBIO with peers

Health Care peers of BBIO on P/S
Stock	P/S	Versus its own history	5-year percentile
ABBVAbbVie	7.8×	Historically high	100
AMGNAmgen	6.4×	Historically high	99
ARWRArrowhead Pharmaceuticals Inc	12.4×	Within its usual range	33
BIIBBiogen	3.7×	Above its usual range	80
BMRNBioMarin Pharmaceutical Inc	3.2×	Historically low	2

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on BBIO

No articles about BBIO yet. How valuation percentiles work

Loading peers and related research…

About this history

What is BBIO's current P/S?: BBIO's P/S of 18.8x is lower than 83% of its weekly readings since August 2022.
What is BBIO's five-year median P/S?: 26.2x. Half of BBIO's weekly readings since August 2022 were higher and half were lower. This page has 221 weekly readings, from Aug 1, 2022 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares BBIO only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.